+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell Analysis Global Market - Forecast to 2029

  • PDF Icon

    Report

  • 708 Pages
  • August 2022
  • Region: Global
  • IQ4I Research & Consultancy Pvt. Ltd
  • ID: 5235151

Cells constitute discrete units of biological function and serve as starting points in a myriad of studies to identify and map many of the basic biochemical and physical processes of life. Cell analysis is important to understand, predict, and ultimately analyze factors that underlie cell health, proliferation, function, and death by using various technologies such as PCR, Sequencing, Microfluidics, Spectrometry, Microscopes, High content analysis and others. All these technologies play a major role in gene, protein and RNA expression analysis of cells, having application in research, diagnosis and therapeutics development. Continuous advancements in technologies significantly revealed the heterogeneity, which will further enhance the cell analysis application.

According to analysis, the cell analysis global market is expected to grow at a low single digit CAGR from 2022 to 2029 to reach $38,020.6 million by 2029. The rising incidence of infectious and non-infectious diseases and demand for early detection, diagnosis & treatment, increasing government and private funding towards cell based research, increasing advancements in cell imaging technologies to reduce the cost & time during the drug discovery process are driving the cell analysis market. Growing focus on personalized medicine and the introduction of advanced technologies in cell analysis provides immense opportunities to the cell analysis market. However, stringent government regulations, availability of alternative technologies, lack of skilled personnel to use advanced cell analysis Instruments, and the high cost of some of the instruments are expected to hamper the market growth.

The market for cell analysis is segmented based on technique, product, application, end-user and geography. The cell analysis techniques global market is segmented into PCR, Sequencing, Microfluidics and Microarrays, Spectrometry, Microscopy, Cytometry, High Content Analysis, Electrophoresis and Others. Among the techniques, the PCR segment accounted for the largest revenue in 2022. The Sequencing segment is expected to grow at a double digit CAGR from 2022 to 2029.

The cell analysis products market is mainly segmented into consumables, instruments, software and services. Among these, consumables segment commanded the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. The software and services segment is expected to grow at a mid single digit CAGR from 2022 to 2029.

The consumables market is further sub-segmented into reagents, assay kits, microplates and others. Among the consumables sub-segments, the assay kits held the largest revenue in 2022. Reagents sub-segment is the fastest growing segment with a mid single digit CAGR from 2022 to 2029.

The instrument segment is further classified into cell counters, cell microarray and microfluidics, liquid handling systems, cytometers, microfluidic devices, high content screening (HCS) systems, microplate readers, PCR devices, sequencing instruments, spectrometer, microscopes and others. Among the instruments, the PCR instruments is commanded the largest revenue of in 2022. Cell Microarrays and Microfluidics are expected to grow at a low single digit CAGR of from 2022 to 2029 due to increasing advancements in microfluidic technologies mainly for single-cell analysis applications.

The application market is categorized based on processes, field, and by therapeutic area. In the process of application, the market is segmented into cellular processes, signal transduction pathways, circulating tumor cells, single-cell analysis, epigenetic target analysis, subpopulation characterization, and drug and candidate screening. Cellular process application accounted for the largest revenue in 2022. The single-cell analysis market is expected to boom at a high single digit CAGR from 2022 to 2029 due to increasing advancement in single-cell technologies. Based on field of application, the market is further segmented into forensic, therapeutics, cell imaging, biomarker research, genomic analysis, stem cell analysis, and diagnostics. Diagnostics held the largest revenue of in 2022. Stem cell analysis is the fastest-growing segment at a mid single digit from 2022 to 2029. The cell imaging market is further segmented into live-cell imaging which is expected to grow at a mid single digit CAGR from 2022 to 2029. Based on therapeutic area, the market is further segmented into cancer, infectious disease, genetic testing, immunology, and others. The Infectious diseases accounted for the largest revenue in 2022. Cancer is the fastest-growing segment with a mid single digit CAGR from 2022 to 2029.

The end-users market is segmented into hospitals & diagnostic laboratories, academic and research institutes, contract research organizations (CROs), pharmaceuticals and biotechnology companies, cell banks, and others. Hospitals & Diagnostic laboratories generated the largest revenue in 2022. Academic and research laboratories are expected to grow at a mid single digit CAGR from 2022 to 2029.

Based on geography, the cell analysis global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K. and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and the Middle East & Africa). North America accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. The factors such as increasing R&D expenditure, increasing incidence of infectious and non-infectious disease, increasing government funding towards the therapeutic and diagnostic research, presence of major players, increasing scope for the cell analysis application in drug discovery, increasing interest towards personalized medicine and development of the innovative platform for high growth potential single-cell analysis application are driving the market.

The Asia-Pacific is the fastest-growing region in the cell analysis global market growing at a low single digit CAGR from 2022 to 2029 which is attributed to the increased scope for research activities in academic & research institutes, increasing outsourcing, increased incidence of chronic diseases (cancer) and infectious disease, increasing awareness about early screening (cancer) and prenatal test and their adoption in clinical care, increasing government and private investment for - cell-based research and also for the development & expansion single-cell analysis technologies and increasing number startup companies engaged in the development innovative solutions. However, lack of technical expertise, high cost of instruments, lack of skilled labors, and large scale clinical data challenges are some of the restraints for the cell analysis market in the region.

The cell analysis global market is competitive and all the players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the cell analysis global market include Agilent Technologies, Inc. (U.S.), Becton Dickinson and Company (U.S.), Illumina Inc. (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), Merck KGaA (Germany), PerkinElmer, Inc. (U.S.), Qiagen N.V. (Netherlands), Thermo Fisher Scientific, Inc. (U.S.), Roche Holdings, Inc. (Switzerland), Abbott Laboratories (U.S.) and 10X Genomics (U.S.)

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

North America

  • U.S.
  • Rest of North America

Europe

  • Germany
  • U.K.
  • France
  • Rest of Europe

Asia-Pacific 

  • Japan
  • China
  • India
  • Rest of APAC

Rest of the World (Row)

  • Brazil
  • Rest of LATAM
  • The Middle East and Africa 


 

Table of Contents


1 Executive Summary
2 Introduction
2.1 Key Takeaways
2.2 Scope of the Report
2.3 Report Description
2.4 Markets Covered
2.5 Stakeholders
2.6 Research Methodology
2.6.1 Market Size Estimation
2.6.2 Market Breakdown & Data Triangulation
2.6.3 Secondary Sources
2.6.4 Key Data Points from Secondary Sources
2.6.5 Primary Sources
2.6.6 Key Data Points from Primary Sources
2.6.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Rising Incidence of Infectious and Non-Infectious Diseases and Demand for Early Detection, Diagnosis & Treatment
3.3.1.2 Increasing Government and Private Funding
3.3.1.3 Increasing Advancements in Cell Imaging Technologies Reduce the Cost and Time Consumption for the Drug Discovery Process
3.3.1.4 Growing Focus on Personalized Medicine
3.3.1.5 Introduction of Advanced Technologies in Cell Analysis
3.3.1.6 Increasing Merger and Acquisition Activities in Cell Analysis
3.3.2 Restraints & Threats
3.3.2.1 Lack of Skilled Personnel to Use Advanced Cell Analysis Instruments
3.3.2.2 Expensive Cell Analysis Instruments
3.3.2.3 Maintaining Consistency, Reproducibility of Assays and Lack of Standardization
3.3.2.4 Availability of Alternative Technologies
3.3.2.5 Stringent Regulatory Framework Limits Advancements in Cellular Analysis Market
3.4 Regulatory Affairs
3.4.1 U.S.
3.4.2 Europe
3.4.3 China
3.4.4 India
3.4.5 Japan
3.5 Funding Scenario
3.6 Cell Analysis - Deals, and New Product Launch
3.7 Technological Advancements
3.7.1 Introduction
3.7.2 Crisper Live Cell Imaging
3.7.3 Single-Cell Multi-Omics
3.7.4 Raman Live Cell Imaging
3.7.5 Droplet-Based Microfluidics in Single-Cell Analysis
3.7.6 Inductively Coupled Plasma Mass Spectrometry in Single-Cell Analysis (Icp-Ms)
3.7.7 Deep Learning and Ai in Microscopy
3.7.8 Intelligent Image-Activated Cell Sorting or Ai-Driven Cell Isolation Technology
3.7.9 Advanced Spatial Technologies in Cell Analysis
3.7.10 Digital Microfluidic Isolation of Single-Cells for -Omics (Disco)
3.8 Impact of Covid-19 on Cell Analysis Market
3.9 Porter's Five Force Analysis
3.9.1 Threat of New Entrants
3.9.2 Threat of Substitutes
3.9.3 Competitive Rivalry
3.9.4 Bargaining Power of Suppliers
3.9.5 Bargaining Power of Buyers
3.1 Market Share Analysis by Major Players
3.10.1 Cell Analysis Global Market Share Analysis
3.10.2 Market Share Analysis by Single-Cell Analysis Major Players
3.11 Company Matrix Analysis

4 Cell Analysis Global Market, Based on Techniques
4.1 Introduction
4.1.1 Pcr (Polymerase Chain Reaction)
4.1.2 Sequencing
4.1.3 Microfluidics and Microarrays
4.1.4 Spectrometry
4.1.5 Microscopy
4.1.6 Cytometry
4.1.7 High Content Screening
4.1.8 Electrophoresis
4.1.9 Others

5 Cell Analysis Global Market, Based on Products
5.1 Introduction
5.2 Consumables
5.2.1 Assay Kits
5.2.2 Reagents
5.2.3 Microplates
5.2.4 Others
5.3 Instruments
5.3.1 Cell Counters
5.3.2 Cell Microarrays and Microfluidics
5.3.3 Liquid Handling Systems
5.3.4 Cytometers
5.3.5 High Content Screening Systems
5.3.6 Microplate Readers
5.3.7 Pcr Instruments
5.3.8 Sequencing Instruments
5.3.9 Spectrometers
5.3.10 Microscopes
5.3.11 Other Instruments
5.4 Software and Services

6 Cell Analysis Global Market, Based on Application
6.1 Introduction
6.2 Cell Analysis Global Market, Based on the Process Of
6.2.1 Cellular Processes
6.2.2 Signal Transduction Pathway
6.2.3 Circulating Tumor Cells
6.2.4 Single-Cell Analysis
6.2.5 Epigenetic Target Analysis
6.2.6 Subpopulation Characterization
6.2.7 Drug and Candidate Screening
6.3 Cell Analysis Global Market, Based on the Field of Application
6.3.1 Forensics
6.3.2 Therapeutics
6.3.3 Genomic Analysis
6.3.4 Stem Cell Analysis
6.3.5 Biomarker Research
6.3.6 Cell Imaging
6.3.6.1 Live-Cell Imaging
6.3.7 Diagnostics
6.4 Cell Analysis Global Market, Based on Therapeutic Area of Applications
6.4.1 Cancer
6.4.2 Genetic Testing
6.4.3 Infectious Diseases
6.4.4 Immunology
6.4.5 Others

7 Cell Analysis Global Market, Based on End-Users
7.1 Introduction
7.2 Hospitals and Diagnostic Laboratories
7.3 Academic & Research Laboratories
7.4 Pharmaceuticals and Biotech Companies
7.5 Contract Research Organisations
7.6 Cell Banks
7.7 Others

8 Regional Market Analysis
8.1 Introduction
8.2 North America
8.2.1 United States (U.S.)
8.2.2 Rest of North America
8.3 Europe
8.3.1 Germany
8.3.2 France
8.3.3 U.K.
8.3.4 Rest of Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Rest of Apac
8.5 Rest of the World
8.5.1 Brazil
8.5.2 Rest of Latin America
8.5.3 Middle East and Africa

9 Competitive Landscape
9.1 Introduction
9.2 New Product Launch
9.3 Approval
9.4 Agreements, Partnerships and Collaborations
9.5 Acquisitions
9.6 Expansion

10 Major Player Profiles
10.1 10X Genomics, Inc.
10.1.1 Overview
10.1.2 Financials
10.1.3 Product Portfolio
10.1.4 Key Developments
10.1.5 Business Strategy
10.1.6 SWOT Analysis
10.2 Abbott Laboratories, Inc
10.2.1 Overview
10.2.2 Financials
10.2.3 Product Portfolio
10.2.4 Key Developments
10.2.5 Business Strategy
10.2.6 SWOT Analysis
10.3 Agilent Technologies, Inc.
10.3.1 Overview
10.3.2 Financials
10.3.3 Product Portfolio
10.3.4 Key Developments
10.3.5 Business Strategy
10.3.6 SWOT Analysis
10.4 Becton Dickinson and Company
10.4.1 Overview
10.4.2 Financials
10.4.3 Product Portfolio
10.4.4 Key Developments
10.4.5 Business Strategy
10.4.6 SWOT Analysis
10.5 Bio-Rad Laboratories, Inc
10.5.1 Overview
10.5.2 Financials
10.5.3 Product Portfolio
10.5.4 Key Developments
10.5.5 Business Strategy
10.5.6 SWOT Analysis
10.6 Danaher Corporation
10.6.1 Overview
10.6.2 Financials
10.6.3 Product Portfolio
10.6.4 Key Developments
10.6.5 Business Strategy.
10.6.6 SWOT Analysis
10.7 F.Hoffmann-La Roche Ltd
10.7.1 Overview
10.7.2 Financials
10.7.3 Product Portfolio
10.7.4 Key Developments
10.7.5 Business Strategy
10.7.6 SWOT Analysis
10.8 Illumina, Inc.
10.8.1 Overview
10.8.2 Financials
10.8.3 Product Portfolio
10.8.4 Key Developments
10.8.5 Business Strategy
10.8.6 SWOT Analysis
10.9 Merck Kgaa
10.9.1 Overview
10.9.2 Financials
10.9.3 Product Portfolio
10.9.4 Key Developments
10.9.5 Business Strategy
10.9.6 SWOT Analysis
10.10 Perkinelmer, Inc.
10.10.1 Overview
10.10.2 Financials
10.10.3 Product Portfolio
10.10.4 Key Developments
10.10.5 Business Strategy
10.10.6 SWOT Analysis
10.11 Qiagen N.V
10.11.1 Overview
10.11.2 Financials
10.11.3 Product Portfolio
10.11.4 Key Developments
10.11.5 Business Strategy
10.11.6 SWOT Analysis
10.12 Thermo Fisher Scientific, Inc.
10.12.1 Overview
10.12.2 Financials
10.12.3 Product Portfolio
10.12.4 Key Developments
10.12.5 Business Strategy
10.12.6 SWOT Analysis

List of Tables
Table 1 Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 2 Cell Analysis Global Market Revenue, Based on Technique, (2021-2029) ($Mn)
Table 3 Pcr in Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 4 Sequencing in Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 5 Microfluidics and Microarray in Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 6 Spectrometry in Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 7 Microscopy in Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 8 Cytometry in Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 9 High Content Screening Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 10 Electrophoresis Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 11 Others Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 12 Cell Analysis Global Market Revenue, Based on Products (2021-2029) ($Mn)
Table 13 Cell Analysis Consumables Global Market Revenue, Based on Product Type (2021-2029) ($Mn)
Table 14 Cell Analysis Consumables Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 15 Cell Analysis Assay Kits Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 16 Cell Analysis Reagents Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 17 Cell Analysis Microplates Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 18 Other Consumables Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 19 Cell Analysis Instruments Global Market Revenue, Based on Product Type (2021-2029) ($Mn)
Table 20 Cell Analysis Instruments Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 21 Cell Counters Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 22 Cell Microarrays and Microfluidics Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 23 Liquid Handling Systems Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 24 Cytometers Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 25 High Content Screening Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 26 Microplate Readers Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 27 Pcr Instruments Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 28 Sequencing Instruments Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 29 Spectrometers Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 30 Microscopes Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 31 Other Instruments Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 32 Software and Services Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 33 Cell Analysis Global Market Revenue, Based on Process of Application, (2021-2029) ($Mn)
Table 34 Cellular Processes Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 35 Signal Transduction Pathway Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 36 Circulating Tumor Cells Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 37 Single-Cell Analysis Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 38 Epigenetic Target Analysis Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 39 Subpopulation Characterization Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 40 Drug and Candidate Screening Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 41 Cell Analysis Global Market Revenue, Based on Field of Application, (2021-2029) ($Mn)
Table 42 Forensics Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 43 Therapeutics Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 44 Genomic Analysis Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 45 Stem Cell Analysis Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 46 Biomarker Research Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 47 Cell Imaging Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 48 Live Cell Imaging Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 49 Diagnostics Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 50 Cell Analysis Global Market Revenue, Based on Therapeutic Area of Application, (2021-2029) ($Mn)
Table 51 Cancer Research Global Market Revenue Based on Region, (2021-2029) ($Mn)
Table 52 Genetic Testing Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 53 Infectious Diseases Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 54 Immunology Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 55 Other Therapeutics Global Market Revenue, Based on Region (2021-2029) ($Mn)
Table 56 Cell Analysis Global Market Revenue, Based on End-Users, (2021-2029) ($Mn)
Table 57 Hospitals and Diagnostic Laboratories Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 58 Academic & Research Laboratories Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 59 Pharma & Biotech Companies Global Market Revenue Based on Region, (2021-2029) ($Mn)
Table 60 Cro's Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 61 Cell Banks Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 62 Other End-Users Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 63 Cell Analysis Global Market Revenue, Based on Region, (2021-2029) ($Mn)
Table 64 North America Cell Analysis Market Revenue, Based on Technique, (2021-2029) ($Mn)
Table 65 North America Cell Analysis Market Revenue, Based on Products, (2021-2029) ($Mn)
Table 66 North America Cell Analysis Consumables Market Revenue, Based on Prodcut Type, (2021-2029) ($Mn)
Table 67 North America Cell Analysis Instruments Market Revenue, Based on Prodcut Type, (2021-2029) ($Mn)
Table 68 North America Cell Analysis Market Revenue, Based on Process of Application, (2021-2029) ($Mn)
Table 69 North America Cell Analysis Market Revenue, Based on Field of Application, (2021-2029) ($Mn)
Table 70 North America Cell Analysis Market Revenue, Based on Therapeutic Area of Application, (2021-2029) ($Mn)
Table 71 North America Cell Analysis Market Revenue, Based on End-User, (2021-2029) ($Mn)
Table 72 North America Cell Analysis Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 73 Europe Cell Analysis Market Revenue, Based on Technique, (2021-2029) ($Mn)
Table 74 Europe Cell Analysis Market Revenue, Based on Products, (2021-2029) ($Mn)
Table 75 Europe Cell Analysis Consumables Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 76 Europe Cell Analysis Instruments Market Revenue, Based on Produt Type, (2021-2029) ($Mn)
Table 77 Europe Cell Analysis Market Revenue, Based on Process of Application, (2021-2029) ($Mn)
Table 78 Europe Cell Analysis Market Revenue, Based on Field of Application, (2021-2029) ($Mn)
Table 79 Europe Cell Analysis Market Revenue, Based on Therapeutic Area of Application, (2021-2029) ($Mn)
Table 80 Europe Cell Analysis Market Revenue, Based on End-User, (2021-2029) ($Mn)
Table 81 Europe Cell Analysis Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 82 APAC Cell Analysis Market Revenue, Basd on Technique,(2021-2029) ($Mn)
Table 83 APAC Cell Analysis Market Revenue, Based on Products, (2021-2029) ($Mn)
Table 84 APAC Cell Analysis Consumables Market Revenue, Based on Produt Type, (2021-2029) ($Mn)
Table 85 APAC Cell Analysis Instruments Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 86 APAC Cell Analysis Market Revenue, Based on Process of Application, (2021-2029) ($Mn)
Table 87 APAC Cell Analysis Market Revenue, Based on Field of Application, (2021-2029) ($Mn)
Table 88 APAC Cell Analysis Market Revenue, Based on Therapeutic Area of Application, (2021-2029) ($Mn)
Table 89 APAC Cell Analysis Market Revenue, Based on End-User, (2021-2029) ($Mn)
Table 90 APAC Cell Analysis Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 91 Row Cell Analysis Market Revenue, Based on Technique, (2021-2029) ($Mn)
Table 92 Row Cell Analysis Market Revenue, Based on Products, (2021-2029) ($Mn)
Table 93 Row Cell Analysis Consumables Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 94 Row Cell Analysis Instruments Market Revenue, Based on Product Type, (2021-2029) ($Mn)
Table 95 Row Cell Analysis Market Revenue, Based on Process of Application, (2021-2029) ($Mn)
Table 96 Row Cell Analysis Market Revenue, Based on Field of Application, (2021-2029)($Mn)
Table 97 Row Cell Analysis Market Revenue, Based on Therapeutic Area of Application, (2021-2029) ($Mn)
Table 98 Row Cell Analysis Market Revenue, by End-User, (2021-2029) ($Mn)
Table 99 Row Cell Analysis Market Revenue, Based on Country, (2021-2029) ($Mn)
Table 100 New Product Launch (2020-2022)*
Table 101 Approvals (2020-2022)*
Table 102 Agreements, Partnerships and Collaborations (2020-2022)*
Table 103 Acquisitions (2020-2022)*
Table 104 Others (2019-2020)
Table 105 10X Genomics, Inc. : Total Revenue and R&D Expenses, (2020-2022)(Q1)($Mn)
Table 106 10X Genomics, Inc. : Total Revenue by Segment, (2020-2022)(Q2) ($Mn)
Table 107 10X Genomics, Inc. : Total Revenue, by Region, (2020-2022)(Q1) ($Mn)
Table 108 Abbott Laboratories, Inc.: Total Revenue and R&D Expenses, (2020 -2022) (Q2) ($Mn)
Table 109 Abbott Laboratories, Inc.: Total Revenue by Segment, (2020-2022)(Q2) ($Mn)
Table 110 Abbott Laboratories, Inc.: Total Revenue by Sub-Segment, (2020-2022)(Q2) ($Mn)
Table 111 Abbott Laboratories, Inc.: Total Revenue, by Region, (2020-2022) (Q2)($Mn)
Table 112 Agilent Technologies, Inc.: Total Revenue and R&D Expenses, (2020-2022) (Q2) ($Mn)
Table 113 Agilent Technologies, Inc.: Total Revenue by Segment, (2020-2022) (Q2) ($Mn)
Table 114 Agilent Technologies, Inc.: Total Revenue, by Region, (2020-2022) (Q2) ($Mn)
Table 115 Becton Dickinson and Company: Total Revenue and R&D Expenses, (2020-2022)(Q2)($Mn)
Table 116 Becton Dickinson and Company: Total Revenue by Segment, (2020-2022) (Q2) ($Mn)
Table 117 Becton Dickinson and Company: Life Sciences Revenue by Sub - Segment, (2020-2022) (Q2) ($Mn)
Table 118 Becton Dickinson and Company: Total Revenue, by Region, (2020-2022) (Q2) ($Mn)
Table 119 Bio-Rad Laboratories, Inc: Total Revenue and R&D Expenses, (2020-2022)(Q1) ($Mn)
Table 120 Bio-Rad Laboratories: Total Revenue by Segment, (2020-2022) (Q1) ($Mn)
Table 121 Bio-Rad Laboratories: Total Revenue, by Region, (2020-2022) (Q1) ($Mn)
Table 122 Danaher Corporation: Total Revenue and R&D Expenses (2020-2022) (Q2) ($Mn)
Table 123 Danaher Corporation: Total Revenue, by Segment, (2020-2022)(Q2) ($Mn)
Table 124 Danaher Corporation: Total Revenue, by Region, (2020-2022) (Q2) ($Mn)
Table 125 F.Hoffmann-La Rache: Total Revenue and R&D Expenses, (2020-2022) (Q2) ($Mn)
Table 126 F.Hoffmann-La Roche: Total Revenue, by Segments, (2020-2022) (Q2) ($Mn)
Table 127 F.Hoffmann-La Roche: Diagnostics Revenue, by Segments (2020-2022) (Q2) ($Mn)
Table 128 F.Hoffman La Roche: Total Revenue, by Geography, (2020-2022) (Q2) ($Mn)
Table 129 Illumina, Inc.: Total Revenue and R&D Expenses, (2020-2021) (Q1) ($Mn)
Table 130 Illumina, Inc.: Total Revenue, by Segments, (2020-2022) (Q1) ($Mn)
Table 131 Illumina, Inc.: Total Revenue, by Geography, (2020-2022)(Q1) ($Mn)
Table 132 Merck Kgaa: Total Revenue and R&D Expenses, (2020-2022) (Q1) ($Mn)
Table 133 Merck Kgaa: Total Revenue, by Segment, (2020-2022) (Q1) ($Mn)
Table 134 Merck Kgaa Company: Total Revenue, by Life-Science Sub-Segments, (2020-2022) (Q1) ($Mn)
Table 135 Merck Kgaa Company: Total Revenue, by Geography, (2020-2022) (Q1) ($Mn)
Table 136 Perkinelmer, Inc.: Total Revenue and R&D Expenses, (2020-2022) (Q1) ($Mn)
Table 137 Perkinelmer, Inc.: Total Revenue by Segment, (2020-2022) (Q1) ($Mn)
Table 138 Perkinelmer, Inc.: Total Revenue, by Region, (2020-2022) (Q2) ($Mn)
Table 139 Qiagen N.V.: Total Revenue and R&D Expenses, (2020 -2022) (Q1) ($Mn)
Table 140 Qiagen N.V.: Total Revenue by Segment, (2020-2022)(Q1) ($Mn)
Table 141 Qiagen N.V.: Total Revenue, by Region, (2020-2022) (Q1)($Mn)
Table 142 Thermo Fisher Scientific, Inc.: Total Revenue and R&D Expenses, (2020-2022) (Q1) ($Mn)
Table 143 Thermo Fisher Scientific, Inc.: Total Revenue, by Segment, (2020-2022) (Q1) ($Mn)
Table 144 Thermo Fisher Scientific, Inc.: Total Revenue, by Geography, (2020-2022)(Q1) ($Mn)

List of Figures
Figure 1 Cell Analysis Global Market Revenue, Based on Geography (2021-2029)($Mn)
Figure 2 Research Methodology: Cell Analysis Global Market
Figure 3 Cell Analysis Global Market: Top-Down and Bottom-Up Approach
Figure 4 Cell Analysis Global Market: Forecasting Model
Figure 5 Cell Analysis Global Market: Market Breakdown & Data Triangulation
Figure 6 Cell Analysis Global Market: Market Segmentation
Figure 7 Market Dynamics
Figure 8 Cell Analysis Global Market: Porter's Analysis
Figure 9 Cell Analysis Global Market Share Analysis, Based on Key Players, (2022) (%)
Figure 10 Single-Cell Analysis Global Market Share Analysis, Based on Key Players, (2022) (%)
Figure 11 Cell Analysis Global Market Share, Based on Techniques (2022 Vs 2029) (%)
Figure 12 Electrophoresis in Cell Analysis Global Market Revenue, Based on Region, (2022 Vs 2029) (%)
Figure 13 Cell Analysis Global Market Revenue, Based on Products and Consumables Sub-Segment, (2022) ($Mn)
Figure 14 Cell Analysis Instruments Global Market Share, Based on Product Type, (2022 Vs 2029) (%)
Figure 15 Cell Analysis Global Market Share, Based on Process of Application (2022 V/S 2029) (%)
Figure 16 Circulating Tumor Cells Global Market Revenue, Based on Region, (2022 Vs 2029) (%)
Figure 17 Cell Analysis Global Market Share, Based on Field of Application (2022 V/S 2029) (%)
Figure 18 Genomic Analysis Global Market Revenue, Based on Region, (2022 Vs 2029) (%)
Figure 19 Cell Analysis Global Market Share, Based on Therapeutic Area of Application (2022 V/S 2029) (%)
Figure 20 Cell Analysis Global Market Share, Based on End-Users (2022 V/S 2029) (%)
Figure 21 Cell Analysis Market Global Revenue, Based on Region (2021-2029) ($Mn)
Figure 22 Cell Analysis Global Market Revenue, Based on Geography (2022) ($ Mn)
Figure 23 North America Cell Analysis Market Share, Based on Technique (2022 V/S 2029) (%)
Figure 24 North America Cell Analysis Market Revenue, Based on Product and Consumables Sub - Segment (2022) ($Mn)
Figure 25 North America Cell Analysis Instruments Market Share, Based on Prodcut Type (2022 Vs 2029) (%)
Figure 26 North America Cell Analysis Market Share, Based on Process of Application (2021 V/S 2029) (%)
Figure 27 North America Cell Analysis Market Share, Based on Field of Application (2022 V/S 2029) (%)
Figure 28 North America Cell Analysis Market Share, Based on Therapeutic Area of Application (2022 V/S 2029) (%)
Figure 29 North America Cell Analysis Market Share, Based on End-User (2022 V/S 2029) (%)
Figure 30 North America Cell Analysis Market Share, Based on Country (2022 V/S 2029) (%)
Figure 31 U.S Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 32 U.S. Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 33 U.S. Cell Analysis Application Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 34 Rest of North America Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 35 Rest of North America Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 36 Rest of North America Cell Analysis Market Revenue, Based on End-User (2022 Vs 2029) ($Mn)
Figure 37 Europe Cell Analysis Market Share, Based on Technique (2022 Vs 2029) (%)
Figure 38 Europe Cell Analysis Market Revenue, Based on Products and Consumables Sub-Segment (2022) ($Mn)
Figure 39 Europe Cell Analysis Instruments Market Share, Based on Product Type (2022 V/S 2029) ($Mn)
Figure 40 Europe Cell Analysis Market Share, Based on Process of Application (2022 V/S 2029) (%)
Figure 41 Europe Cell Analysis Market Share, Based on Field of Application (2022 V/S 2029) (%)
Figure 42 Europe Cell Analysis Market Share, Based on Therapeutic Area Application (2022 V/S 2029) (%)
Figure 43 Europe Cell Analysis Market Share, Based on End-User (2022 V/S 2029) (%)
Figure 44 Europe Cell Analysis Market Share, Based on Country (2022 V/S 2029) (%)
Figure 45 Germany Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 46 Germany Cell Analysis Market Revenue, Based on Field of Application and Theraputic Area of Application (2022 V/S 2029) ($Mn)
Figure 47 Germany Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 48 France Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 49 France Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 50 France Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 51 U.K. Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 52 U.K. Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 53 U.K. Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 54 Rest of Europe Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 55 Rest of Europe Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 56 Rest of Europe Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 57 APAC Cell Analysis Market Share, Based on Technique (2022) (%)
Figure 58 APAC Cell Analysis Market Revenue, Based on Products and Consumables Sub-Segment (2022) ($Mn)
Figure 59 APAC Cell Analysis Market Share, Based on Instruments (2022 V/S 2029) (%)
Figure 60 APAC Cell Analysis Market Share, by Process of Application (2022 V/S 2029) (%)
Figure 61 APAC Cell Analysis Market Share, Based on Field of Application (2022 V/S 2029) (%)
Figure 62 APAC Cell Analysis Market Share, Based on Therapeutic Area of Application (2022 V/S 2029) (%)
Figure 63 APAC Cell Analysis Market Share, Based on End-User (2022 V/S 2029) (%)
Figure 64 APAC Cell Analysis Market Share, Based on Country (2022 V/S 2029) (%)
Figure 65 Japan Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 66 Japan Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 67 Japan Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 68 China Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 69 China Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 70 China Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 71 India Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 72 India Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 73 India Cell Analysis Market Revenue, Based on End-User (2022 Vs 2029) ($Mn)
Figure 74 Rest of APAC Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 75 Rest of APAC Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 76 Rest of APAC Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 77 Rest of the World Cell Analysis Market Share, Based on Technique (2022) (%)
Figure 78 Rest of the World Cell Analysis Market Share, Based on Products and Consumables Sub-Segment (2022) ($Mn)
Figure 79 Rest of the World Cell Analysis Market Share, Based on Instruments (2022 V/S 2029) (%)
Figure 80 Rest of the World Cell Analysis Market Share, Based on Process of Application (2022 V/S 2029) (%)
Figure 81 Rest of the World Cell Analysis Market Share, Based on Field of Application (2022 V/S 2029) (%)
Figure 82 Rest of the World Cell Analysis Market Share, Based on Therapeutic Area Application (2022 V/S 2029) (%)
Figure 83 Rest of the World Cell Analysis Market Share, Based on End-User (2022 V/S 2029) (%)
Figure 84 Rest of the World Cell Analysis Market Share, Based on Country (2022 V/S 2029) (%)
Figure 85 Brazil Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 86 Brazil Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 87 Brazil Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 88 Rest of Latam Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 89 Rest of Latam Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 90 Rest of Latam Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 91 Middle East and Africa Cell Analysis Market Revenue, Based on Products, Process of Application (2022 V/S 2029) ($Mn)
Figure 92 Middle East and Africa Cell Analysis Market Revenue, Based on Field of Application, Therapeutic Area of Application (2022 V/S 2029) ($Mn)
Figure 93 Middle East and Africa Cell Analysis Market Revenue, Based on End-User (2022 V/S 2029) ($Mn)
Figure 94 Key Growth Strategies (2020-2022*)
Figure 95 SWOT: 10X Genomics
Figure 96 SWOT: Abbott Laboratories, Inc.
Figure 97 SWOT: Agilent Technologies
Figure 98 SWOT: Becton Dickinson and Company
Figure 99 SWOT: Bio-Rad Laboratories Inc.
Figure 100 SWOT: Danaher Corporation
Figure 101 SWOT: F. Hoffmann-La Roche Ltd.
Figure 102 SWOT: Illumina Inc.
Figure 103 SWOT: Merck Kgaa
Figure 104 SWOT: Perkinelmer, Inc
Figure 105 SWOT: Qiagen N V
Figure 106 SWOT: Thermo Fisher Scientific

Samples

Loading
LOADING...

Companies Mentioned

  • 10X Genomics
  • 1CellBio
  • Abbexa Ltd
  • Abbott Laboratories, Inc.
  • Abcam Plc.
  • Abnova Corporation
  • ABP Biosciences LLC
  • Adaptive Biotechnologies Corp.
  • Agilent Technologies Inc. (U.S.)
  • Aigenpulse
  • Akadeum Life Sciences
  • Akoya Biosciences, Inc.
  • Alit Lifesciences Co., Ltd
  • Altona Diagnostics GmbH
  • Analytik Jena AG (CyBio AG)
  • ArrayGen Technologies Pvt Ltd (India)
  • Art Robbins Instruments LLC (U.S.)
  • Aviva Bioscience (U.S.)
  • Axion Biosystems (CytoSMART Technologies B.V.) (U.S.)
  • Azenta Life Sciences (Brooks life sciences)
  • Becton Dickinson and Company
  • BennuBio Inc.
  • Berry Genomics Co., Ltd
  • BGI Group
  • Bico (Cellenion)
  • Bio View Ltd.
  • BioAgilytix Labs, LLC (Cambridge Biomedical Inc.)
  • Biochrom Ltd.
  • Biofluidica
  • BioinGentech
  • Bioneer Corporation
  • Bio-Rad Laboratories Inc.
  • Bioron GmbH
  • BioSkryb, Inc.
  • Bio-Techne Corporation
  • Biotium
  • bitBiome, Inc.
  • Blue-Ray Biotech
  • Brand GMBH
  • Bruker Corporation
  • Carl Zeiss AG
  • CeGaT GmbH
  • Cell Biolabs, Inc.
  • Cell Microsystems
  • Cell Signaling Technology, Inc.
  • CellChorus
  • CellTool
  • Celsius Therapeutics
  • Celtic Molecular Diagnostics
  • Cherry Biotech
  • Cleaver Scientific
  • Corning Inc.
  • Cytek Biosciences
  • CytoTronics
  • Da An Gene Co., Ltd.,
  • DeepCell, Inc.
  • DiaSorin (Luminex Corporation)
  • DLAB Scientific Co., Ltd.,
  • Dolomite Bio
  • Eikon Therapeutics
  • Element Biosciences
  • Enzo life sciences Inc.
  • Epigenomics AG
  • Eppendorf
  • Etaluma Inc
  • Eurofins Scientific
  • Fluent BioSciences
  • Fluidigm Corporation
  • Fluxion Biosciences
  • GC biotech B.V.
  • Genomatix AG
  • GenXPro GmbH
  • Hamilton Company
  • Hausser Scientific
  • Helena Laboratories Corporation
  • Herolab GmbH
  • Hettich Lab Technology
  • HighQu GmbH
  • Horiba, Ltd
  • Illumina Inc.
  • Immunai
  • IncellDx
  • Inscopix
  • Insightful Science
  • IsoPlexis
  • Jasco Analytical Instruments
  • JEOL Ltd
  • Keyence Corporation
  • Kinetic River Corp.
  • Known Medicine
  • Kromatid
  • Kyratec
  • LABGENE Scientific SA
  • Levitas Bio
  • LGC Ltd (Biosearch Technologies)
  • Lucid Scientific
  • Lonza Group
  • Lunaphore Technologies
  • LungLife AI, Inc
  • LW Scientific
  • Macrogen Inc
  • Meiji Techno Co., Ltd
  • Menarini Silicon Biosystems
  • Merck KGaA
  • METAFORA biosystems
  • Micro-Shot Technology Ltd.
  • Miltenyil Biotec GmbH
  • Minos Biosciences
  • Mission Bio, Inc.
  • Myllia Biotechnology (Aelian Biotechnology)
  • Namocell Inc.
  • Nanolive SA
  • NanoString Technologies, Inc.
  • Nikon Corporation
  • Novogene Co. Ltd
  • Nucleai
  • Oxford Nanopore Technologies, Ltd.
  • Pacific Biosciences
  • Paradigm4
  • Parse Biosciences
  • PerkinElmer
  • Picoquant GmbH
  • Plexium
  • Polaris Biology
  • Promega Corporation
  • Promocell
  • Qiagen N.V
  • Rebus Biosystems
  • Renishaw plc
  • Roche Diagnostics
  • Rosalind, Inc.
  • S2 Genomics, Inc.
  • Sartorius AG
  • Scailyte AG
  • Scipio bioscience S.A.S
  • Scopio Labs
  • seqWell
  • Single Cell Discoveries
  • Singleron Biotechnologies. Inc
  • Singular Genomics Systems, Inc
  • Sony Biotechnology
  • Sphere Fluidics
  • StemCell Technologies
  • Stilla Technologies
  • Sysmex Coperation
  • Olympus Corporation
  • Optika Srl
  • Takara Bio
  • ThinkCyte
  • Tomocube Inc.
  • Tracxn Technologies Limited (Capp Aps)
  • Visitron Systems GmbH
  • Vizgen, Inc.
  • Yokogawa Electric Corporation
  • Zymo Research